08:00 , Feb 10, 2014 |  BC Week In Review  |  Company News

Endo, Boca Pharmacal deal

Endo's Qualitest subsidiary completed its acquisition of generics company Boca Pharmacal for about $225 million in cash (see BioCentury, Sept. 2, 2103). Endo Health Solutions Inc. (NASDAQ:ENDP), Chadds Ford, Pa.   Boca Pharmacal LLC ,...
07:00 , Sep 2, 2013 |  BC Week In Review  |  Company News

Boca Pharmacal LLC, Endo deal

Endo's Generics International Inc. subsidiary will acquire generics company Boca Pharmacal for $225 million in cash. Boca focuses on developing controlled substances, semisolids and solutions. Endo said Boca is expected to have an EBITDA of...